Print Page | Contact Us | Report Abuse | Sign In | Register
Webinar: Contingency Management: An Underused Treatment Approach for Opioid Use Disorder
Tell a Friend About This EventTell a Friend
 

This webinar will review the theory of CM and its origins in operant conditioning, its evidence base of 40 random controlled trials, and current understandings of best practices for effective use of CM – including what is not fully known.

3/13/2018
When: Tuesday, 03/13/2018
1:00 PM - 3:00 PM
Where: United States
Presenter: David R. Gastfriend, MD, DFASAM
Contact: Lee Ann Griffin
(850) 878-2196

« Go to Upcoming Event List  

 

Although research supports the efficacy of Contingency Management (CM) as an evidence-based practice for treatment of substance use disorders, it is not widely used. This webinar will review the theory of CM and its origins in operant conditioning, its evidence base of 40 random controlled trials, and current understandings of best practices for effective use of CM – including what is not fully known. We will also examine the logistical, financial, ethical and training obstacles that have impeded adoption of CM and the ways in which new technologies may solve these challenges to facilitate widespread adoption of CM into routine clinical care.

Who should attend?
This webinar is designed for clinicians, clinical supervisors, program managers, prevention agencies, community coalitions and executives in substance abuse and mental health agencies, Managing Entities and DCF program staff.

Presented by:
Dr. Gastfriend is a Senior Research Scientist at the Treatment Research Institute (TRI). An addiction psychiatrist, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, the NIAAA COMBINE Study and the NIDA Clinical Trials Network. As Vice President at Alkermes, Inc., Dr. Gastfriend conducted biological, clinical, health economics and policy research on behalf of the company’s efforts in the field of addiction treatment. For 25 years, Dr. Gastfriend served on the faculty of Harvard Medical School, notably as the Director of the Addiction Research Program at Massachusetts General Hospital and founder of the MGH/McLean Hospital Fellowship in Addiction Psychiatry. He is considered the world’s leading expert on two important treatment tools from both the biological and psychosocial realms: the opioid blocker Vivitrol, and the American Society of Addiction Medicine (ASAM) Criteria Software.  Dr. Gastfriend’s ASAM Criteria research contributed to their endorsement by most U.S. states, the VA and DOD. His 150 scientific publications include The ASAM Criteria and Addiction Treatment Matching. His CONTINUUM – The ASAM Criteria Decision Engine™ and ASAM’s CO-Triage™ are being used across Los Angeles County, the California state prison system, Massachusetts, and elsewhere. Dr. Gastfriend’s newest project is DynamiCare Health™, a technology platform for scaling up Contingency Management treatment and machine learning predictive analytics for routine care. He has consulted to the governments of Belgium, China, Iceland, Israel, Norway, Russia and the U.S. He received his B.A. at Haverford College in Philadelphia, and his M.D. from Jefferson Medical College in Philadelphia.

 
CEUs:
2 Continuing Education Units/Contact Hours are provided for this event
Florida Certification Board Approved Education Provider, #001-A
Florida Board of Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #50-676
Florida Board of Nursing Provider #50-676